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Abscesses in the Liver: Amoebic or Pyogenic?
B. Jamil,S. S. Hamid ( Departments of Medicine and Microbiology, The Aga Khan University Hospital, Karachi. ) 
Liver abscess is a common condition in our part of the world. This is not surprising if one looks at the
epidemiology of amoebiasis. The prevalence of infection with E. histolytica and E. dispar is as high as
50% in the underdeveloped areas, where asymptomatic intestinal infection occurs in 90 to 99% of
infected individuals and confers a 10% risk per year of symptomatic invasive amoebiasis1. However,
apart from Entamoeba histolytica, liver abscess may also be caused by other pathogens, including
enteric gram-negative bacteria and pyogenic gram-positive cocci. Occasionally, salmonella, brucella,
mycobacteria and even fungi have been known to produce abscesses in the liver. Pyogenic liver
abscess, however, is an uncommon entity. Not unexpectedly, it is more common than amoebic liver
abscess in the developed world: a direct reflection of prevalence of E. histolytica in these areas2,3.
How does a liver abscess evolve? The liver is prone to microbial invasion by virtue of its anatomical
location and function. Most of the blood from the large gut drains into the right lobe of the liver
through the portal system. Organisms passing through the hepatic sinusoids are trapped, phagocytosed
and killed by the hepatic mononuclear-macrophage system. An abscess develops when these
phagocytic cells fail to eradicate the microbes, either because of some intrinsic defect in their function
or because of the virulence of the infecting organisms. Micoorganisms that evade phagocytosis and
intracellular killing, subsequently inflict cellular injury, directly and/or through release of lytic enzymes
and toxins.
Conditions like appendicitis, diverticulitis or inflammatory bowel disease, where the infectious process
is in the bed of the portal venous circulation, lead to pyogenic liver abscesses through suppurative
thrombophlebitis. Apart from portal circulation, the liver may be infected from the biliary tract,
secondary to a calculus, stricture or malignancy. Biliary disease is now the most common source of
pyogenic abscess4. Liver abscess can also arise from infection of the gall bladder, through the blood
stream from infected foci anywhere in the body, and following direct trauma. About one-fourth of the
cases are cryptogenic, i.e., no source can be identified and are probably caused by infection of infracted
portions of the liver. Pyogenic liyer abscesses may develop in patients with sickle cell anemia5 and as
an infectious complication of liver transplantation6.
Liver abscesses caused by E. histolytica complicate 3-9% of cases of amoebic colitis2. Although there
is no sex predominance in bacterial liver abscesses, more than 90% of amoebic liver abscesses occur in
men; patients with amoebic liver abscesses are generally younger than those with bacterial abscesses1.
Pyogenic liver abscess is frequently polymicrobial and enteric gram-negative bacilli are generally
cultured from the aspirated pus. The specific types of microorganisms that cause liver abscess probably
vary with the underlying disease. The high frequency of “sterile” abscesses, reported in some series to
be about 50% is probably a result of inadequate anaerobic cultivation. As a result of modern anaerobic
bacteriologic techniques, anaerobic bacteria are now recognized as a major cause of liver abscesses.
When modern anaerobic culture techniques are used, about 50% of all pyogenic liver abscesses have
been found to be caused by anaerobes7 with positive blood cultures in 54% of these cases.
Staphylococcus aureus and group A streptococcus account for 20% or less of cases. Candida may
invade the liver as part of a systemic infection in patients with acute leukemia and produce
microabscesses.
In the past, it was believed that 10-20% of amoebic liver abscesses were secondarily infected with
bacteria, usually of enteric origin. However, in more recent series, superinfection was found to have
occurred in only upto 4% of cases8.
Both amoebic and pyogenic abscesses can be single or multiple. Multiple pyogenic abscesses are more
apt to be caused by biliary tract disease whereas abscesses arising via the portal vein are usually
solitary; the right lobe is more commonly involved than the left.
Clinical differentiation of amoebic from a pyogenic liver abscess is based on the clinical presentation
and recognition of epidemiologic risk factors, a lack of predisposing conditions for pyogenic liver
abscess, and early use of noninvasive imaging studies. History of dysentery may not be available.
Concomitant diarrhea occurs in 30 to 40% of patients; amoebae are found in stool by microscopic
examination even less frequently1. Although older studies emphasize that an amoebic liver abscess
presents as a single large lesion in the right lobe of the liver, studies using modern imaging technology
demonstrate a high frequency of multiple lesions9. Abscess may be aspirated if there is a high suspicion
of pyogenic infection, in which case aspiration is both diagnostic and therapeutic.
The differentiation of amoebic from a pyogenic liver abscess is greatly assisted by amoebic serology,
since laboratory tests like liver function tests and stool microscopy are non-discriminatory, facilities for
culture are lacking and the positivity rate of bacterial culture (aspirate, blood) is only around 50%. For
this reason, the anti-amoebic antibodies, in significant titres, constitute the defmitive diagnostic test of
amoebic liver abscess. The antibodies are positive in up to 99% of patients with invasive amoebiasis1.
Sensitivity of serology is generally quoted to be approx. 90% for amoebic liver abscess10. In a local
study on 100 liver abscesses, the indirect haemagglutination test (IHA) was found to be 100% sensitive
and 94% specific for amoebic liver abscess11. The cut off point of antibody titre between normal
population and patients with invasive amoebiasis has been found to be 1:128 in an endemic
population”. Antibodies persist for a long time after resolution of infection, the titre and duration of
persistence may not be influenced by early institution of specific chemotherapy12. Furthermore, IHA
test has been shown to remain positive for 20 years after infection13.
Therefore, serologic tests for amoebiasis should be interpreted with caution. A physician practising in
an endemic area must bear in mind the frequent occurrence of asymptomatic infection with pathogenic
E. histolytica, which leads to the high prevalence (10-35% of population) of serum anti:amoebic
antibodies10. Another possible pitfall in interpretation would be in patients with an acute presentation
of less than 7 days, when serologic studies may be negative.
Based on relevant clinical data, most cases of amoebic liver abscess can be diagnosed and treated
without aspiration. In some cases, antimicrobials directed against enteric gram negative organisms may
be added to metronidazole therapy, pending the results of serologic studies. Therapeutic trials of
specific anti-amoebic therapy can be helpful diagnostically; most patients respond within 3 days with
decreased pain and fever, The liver abscess cavity usually resolves gradually over months but persistent
cystic lesions are not unusual. Serial ultrasonography has shown that at 6 months after successful
treatment, only one-third to two-thirds of amoebic liver abscesses resolve completely10. Persistence of
cystic lesions, presence of E. histolytica cysts in stool in carriers and high titres of anti-amoebic
antibodies in endemic population are some of the confounding factors, which should be kept in mind in
the work-up of a patient suspected to have liver abscess.
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